参考文献/References:
[1]. Pasupathy SAir T, Dreyer RP, et al. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries[J]. Circulation,2015,131(19):861-870.
[2]. Montone RA,Niccoli G,Fracassi F,et al. Patients with acute myocardial infarction and non-obstructive coronary arteries:safety and prognostic relevance of invasive coronary provocative tests[J]. Eur Heart J,2018,39(2):91-98.
[3].[3] Ong P,Camici PG,Beltrame JF,et al. International standardization of diagnostic criteria for microvascular angina[J]. Int J Cardiol,2018,250(1):16-20.
[4].[4] Agewall S,Beltrame JF,Reynolds HR,et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries[J]. Eur Heart J,2017,38(3):143-153.
[5].[5] Pelliccia F,Greco C,Vitale C,et al. Takotsubo syndrome(stress cardiomyopathy): an intriguing clinical condition in search of its identity[J]. Am J Med,2014,127(8):699-704.
[6].[6] Tornvall P,Gerbaud E,Behaghel A,et al. Myocarditis or "true" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: a meta-analysis of individual patient data[J]. Atherosclerosis,2015,241(1):87-91.
[7].[7] Cuculi F,Togni M,Meier B. Myocardial infarction due to paradoxical embolism in a patient with large atrial septal defect[J]. J Invasive Cardiol,2009,21(10):184-186.
[8].[8] Group JCSJW. Guidelines for diagnosis and treatment of patients with vasospastic angina(Coronary Spastic Angina)(JCS 2013) [J]. Circ J,2014,78(11):2779-2801.
[9].[9] Opolski MP,Spiewak M,Marczak M,et al, Mechanisms of myocardial infarction in patients with nonobstructive coronary artery disease: results from the optical coherence tomography study[J].JACC Cardiovasc Imaging,2018, 72(13):252-253.
[10].[10] Scalone G,Niccoli G,Crea F,et al. Editor’s choice—Pathophysiology,diagnosis and management of MINOCA:an update[J]. Eur Heart J Acute Cardiovasc Care,2018, 8(1):54-62.
[11].[11] Bil J, Pietraszek N, Pawlowski T, et al. Advances in mechanisms and treatment options of MINOCA caused by vasospasm or microcirculation dysfunction[J]. Curr Pharm Des,2018,24(4):952.
[12].[12] Hong MK,Park SW,Lee CW,et al. Intravascular ultrasound findings of negative arterial remodeling at sites of focal coronary spasm in patients with vasospastic angina[J]. Am Heart J,2000,140(3):395-401.
[13].[13] Saito S, Yamagishi M, Takayama T,et al. Plaque morphology at coronary sites with focal spasm in variant angina:study using intravascular ultrasound[J]. Circ J,2003,67(12):1041-1045.
[14].[14] Jia H, Abtahian F,Aguirre AD,et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography[J]. J Am Coll Cardiol,2013,62(19):1748-1758.
[15].[15] Morikawa Y,Uemura S,Ishigami K,et al. Morphological features of coronary arteries in patients with coronary spastic angina:assessment with intracoronary optical coherence tomography[J]. Int J Cardiol,2011,146(3):334-340.
[16].[16] Cacciotti L,Passaseo I,Marazzi G,et al. Observational study on Takotsubo-like cardiomyopathy:clinical features,diagnosis,prognosis and follow-up[J]. BMJ Open,2012,2(5):231-239.
[17].[17] Tsujita K,Sakamoto K,Kojima S,et al. Coronary plaque component in patients with vasospastic angina:a virtual histology intravascular ultrasound study[J]. Int J Cardiol,2013,168(3):2411-2415.
[18].[18] Ong P,Athanasiadis A,Borgulya G,et al. Clinical usefulness,angiographic characteristics,and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries[J]. Circulation,2014,129(17):1723-1730.
[19].[19] Beltrame JF,Crea F,Kaski JC,et al. The who, what, why, when, how and where of vasospastic angina[J]. Circ J,2016,80(2):289-298.
[20].[20] Wei J,Mehta PK,Johnson BD,et al. Safety of coronary reactivity testing in women with no obstructive coronary artery disease:results from the NHLBI-sponsored WISE(Women’s Ischemia Syndrome Evaluation) study[J]. JACC Cardiovasc Interv,2012,5(6):646-653.
[21].[21] Sun Y,Mao D,Lu F,et al. Diagnosis of dissection of the coronary artery dissection by multidetector computed tomography: a comparative study with coronary angiology[J]. J Comp Assist Tomogr,2015,39(4):572-577.
[22].[22] Roffi M, Patrono C,Collet JP,et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology(ESC)[J]. G Ital Cardiol(Rome),2016,17(10):831-872.
[23].[23] Lindahl B,Baron T,Erlinge D,et al. Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease clinical perspective[J]. Circulation,2017,135(16):1481-1489.
[24]. [24] Jernberg T,Attebring MF,Hambraeus K,et al.The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies(SWEDEHEART)[J]. Heart, 2010,96(20):1617-1621.
[25].[25] Bangalore S,Steg G,Deedwania P,et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease[J].JAMA,2012,308(13):1340-1349.
[26].[26] Templin C,Ghadri JR,Diekmann J,et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy[J]. N Engl J Med,2015,373(10):929-938.
[27].[27] Kuhl U,Lassner D,von Schlippenbach J,et al. Interferon-Beta improves survival in enterovirus-associated cardiomyopathy[J]. JACC,2012,60(14):1295-1296.